{"title":"难治性抑郁症概念的临床不足:评估和心理治疗管理的创新策略","authors":"Jenny Guidi , Giovanni A. Fava","doi":"10.1016/j.cpr.2025.102616","DOIUrl":null,"url":null,"abstract":"<div><div>Pharmacological strategies have been developed for patients with major depressive disorder who fail to respond to standard drug treatment. The current clinical approach primarily relies on counting episodes that fulfill specific criteria and regards non-pharmacological strategies as of marginal value, despite their recognized importance in treating depression. Most attention is devoted to treatment-resistant patients' characteristics rather than to the process related to therapeutic management. However, how the patient experiences the treatment process, his/her interaction with the physician/therapist and significant others, and the patient's role in treatment plan (self-management) are all essential therapeutic components. A broader evaluation of factors related to the patient (e.g., illness denial, psychological reactance, demoralization), the therapy (e.g., clinician's attitude, behavioral toxicity of antidepressants), the environment (e.g., allostatic load/overload and health-damaging behaviors), and morbidity (e.g., medical and psychiatric comorbidity) is warranted. Assessment based on clinimetric methods (i.e., staging, macro-analysis) and clinical judgment allow a differential diagnosis of phenomena such as non-response, pseudo-resistance, treatment resistance, loss of clinical effect during maintenance antidepressant treatment, failure to achieve remission after a psychotherapy trial, partially remitted depression (i.e., presence of residual symptoms). Choice of the psychotherapeutic approach for treatment-resistant depression (TRD), particularly cognitive-behavioral therapy, mindfulness-based cognitive therapy and interpersonal psychotherapy, should follow the indications derived from clinical assessment. Treatment of TRD can thus be conceptualized as an integrated therapeutic approach to different components encompassing symptoms, psychosocial factors, lifestyle and psychological well-being.</div></div>","PeriodicalId":48458,"journal":{"name":"Clinical Psychology Review","volume":"120 ","pages":"Article 102616"},"PeriodicalIF":13.7000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The clinical inadequacy of the concept of treatment-resistant depression: Innovative strategies in assessment and psychotherapeutic management\",\"authors\":\"Jenny Guidi , Giovanni A. Fava\",\"doi\":\"10.1016/j.cpr.2025.102616\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Pharmacological strategies have been developed for patients with major depressive disorder who fail to respond to standard drug treatment. The current clinical approach primarily relies on counting episodes that fulfill specific criteria and regards non-pharmacological strategies as of marginal value, despite their recognized importance in treating depression. Most attention is devoted to treatment-resistant patients' characteristics rather than to the process related to therapeutic management. However, how the patient experiences the treatment process, his/her interaction with the physician/therapist and significant others, and the patient's role in treatment plan (self-management) are all essential therapeutic components. A broader evaluation of factors related to the patient (e.g., illness denial, psychological reactance, demoralization), the therapy (e.g., clinician's attitude, behavioral toxicity of antidepressants), the environment (e.g., allostatic load/overload and health-damaging behaviors), and morbidity (e.g., medical and psychiatric comorbidity) is warranted. Assessment based on clinimetric methods (i.e., staging, macro-analysis) and clinical judgment allow a differential diagnosis of phenomena such as non-response, pseudo-resistance, treatment resistance, loss of clinical effect during maintenance antidepressant treatment, failure to achieve remission after a psychotherapy trial, partially remitted depression (i.e., presence of residual symptoms). Choice of the psychotherapeutic approach for treatment-resistant depression (TRD), particularly cognitive-behavioral therapy, mindfulness-based cognitive therapy and interpersonal psychotherapy, should follow the indications derived from clinical assessment. Treatment of TRD can thus be conceptualized as an integrated therapeutic approach to different components encompassing symptoms, psychosocial factors, lifestyle and psychological well-being.</div></div>\",\"PeriodicalId\":48458,\"journal\":{\"name\":\"Clinical Psychology Review\",\"volume\":\"120 \",\"pages\":\"Article 102616\"},\"PeriodicalIF\":13.7000,\"publicationDate\":\"2025-06-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Psychology Review\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0272735825000832\",\"RegionNum\":1,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHOLOGY, CLINICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Psychology Review","FirstCategoryId":"102","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0272735825000832","RegionNum":1,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
The clinical inadequacy of the concept of treatment-resistant depression: Innovative strategies in assessment and psychotherapeutic management
Pharmacological strategies have been developed for patients with major depressive disorder who fail to respond to standard drug treatment. The current clinical approach primarily relies on counting episodes that fulfill specific criteria and regards non-pharmacological strategies as of marginal value, despite their recognized importance in treating depression. Most attention is devoted to treatment-resistant patients' characteristics rather than to the process related to therapeutic management. However, how the patient experiences the treatment process, his/her interaction with the physician/therapist and significant others, and the patient's role in treatment plan (self-management) are all essential therapeutic components. A broader evaluation of factors related to the patient (e.g., illness denial, psychological reactance, demoralization), the therapy (e.g., clinician's attitude, behavioral toxicity of antidepressants), the environment (e.g., allostatic load/overload and health-damaging behaviors), and morbidity (e.g., medical and psychiatric comorbidity) is warranted. Assessment based on clinimetric methods (i.e., staging, macro-analysis) and clinical judgment allow a differential diagnosis of phenomena such as non-response, pseudo-resistance, treatment resistance, loss of clinical effect during maintenance antidepressant treatment, failure to achieve remission after a psychotherapy trial, partially remitted depression (i.e., presence of residual symptoms). Choice of the psychotherapeutic approach for treatment-resistant depression (TRD), particularly cognitive-behavioral therapy, mindfulness-based cognitive therapy and interpersonal psychotherapy, should follow the indications derived from clinical assessment. Treatment of TRD can thus be conceptualized as an integrated therapeutic approach to different components encompassing symptoms, psychosocial factors, lifestyle and psychological well-being.
期刊介绍:
Clinical Psychology Review serves as a platform for substantial reviews addressing pertinent topics in clinical psychology. Encompassing a spectrum of issues, from psychopathology to behavior therapy, cognition to cognitive therapies, behavioral medicine to community mental health, assessment, and child development, the journal seeks cutting-edge papers that significantly contribute to advancing the science and/or practice of clinical psychology.
While maintaining a primary focus on topics directly related to clinical psychology, the journal occasionally features reviews on psychophysiology, learning therapy, experimental psychopathology, and social psychology, provided they demonstrate a clear connection to research or practice in clinical psychology. Integrative literature reviews and summaries of innovative ongoing clinical research programs find a place within its pages. However, reports on individual research studies and theoretical treatises or clinical guides lacking an empirical base are deemed inappropriate for publication.